BioSig Technologies Files 8-K
Ticker: STEX · Form: 8-K · Filed: May 5, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
BioSig filed an 8-K, check for updates.
AI Summary
BioSig Technologies, Inc. filed an 8-K on May 5, 2025, reporting other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates that BioSig Technologies, Inc. has made a regulatory submission to the SEC, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural document without immediate disclosed financial impact or significant operational changes.
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- May 5, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38659 (identifier) — SEC File Number
- 26-4333375 (identifier) — IRS Employer Identification No.
FAQ
What specific events are being reported in this 8-K filing?
The provided text indicates the filing is for 'Other Events' and 'Financial Statements and Exhibits' but does not detail the specific nature of these events.
When was this 8-K report filed?
The report was filed on May 5, 2025.
What is the principal executive office address for BioSig Technologies, Inc.?
The principal executive offices are located at 12424 Wilshire Blvd, Ste 745, Los Angeles, California, 90025.
What is the company's telephone number?
The registrant's telephone number is (203) 409-5444.
What is the SIC code for BioSig Technologies, Inc.?
The Standard Industrial Classification code is 3845, for ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 5, 2025 regarding BioSig Technologies, Inc. (STEX).